ACADIA PHARMACEUTICALS INC - COM (ACAD)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
158 M
Holdings value Q1 2024
$2.92 B
Value change Q1 2024
-$57.5 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
257
Number of buys Q1 2024
144
Number of sells Q1 2024
-128
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
004225108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 158 M $2.92 B -$57.5 M $18.49 257
2023 Q4 158 M $4.94 B +$168 M $31.31 273
2023 Q3 154 M $3.22 B -$78.8 M $20.84 245
2023 Q2 157 M $3.75 B +$21.9 M $23.95 232
2023 Q1 157 M $2.96 B +$53.6 M $18.82 227
2022 Q4 155 M $2.48 B +$28.4 M $15.92 217
2022 Q3 147 M $2.4 B +$23.5 M $16.36 201
2022 Q2 150 M $2.11 B +$2.6 M $14.09 227
2022 Q1 146 M $3.54 B -$24.6 M $24.22 249
2021 Q4 148 M $3.44 B +$76.4 M $23.34 237
2021 Q3 145 M $2.4 B -$86.1 M $16.61 229
2021 Q2 148 M $3.6 B +$55.7 M $24.39 235
2021 Q1 145 M $3.73 B -$222 M $25.80 257
2020 Q4 147 M $7.86 B -$112 M $53.46 295
2020 Q3 150 M $6.18 B -$101 M $41.25 257
2020 Q2 153 M $7.39 B -$49.3 M $48.47 290
2020 Q1 153 M $6.48 B +$187 M $42.25 235
2019 Q4 149 M $6.38 B +$117 M $42.78 266
2019 Q3 146 M $5.26 B +$305 M $35.99 225
2019 Q2 138 M $3.69 B +$175 M $26.73 195
2019 Q1 138 M $3.7 B -$504 K $26.85 195
2018 Q4 139 M $2.25 B +$303 M $16.17 174
2018 Q3 118 M $2.45 B +$122 M $20.76 179
2018 Q2 117 M $1.78 B -$131 M $15.27 177
2018 Q1 122 M $2.74 B +$37.7 M $22.47 191
2017 Q4 120 M $3.61 B +$37.2 M $30.11 206
2017 Q3 117 M $4.4 B -$40.7 M $37.67 205
2017 Q2 118 M $3.29 B +$72.2 M $27.89 198
2017 Q1 119 M $4.11 B +$169 M $34.38 211
2016 Q4 120 M $3.46 B +$99.4 M $28.84 219
2016 Q3 118 M $3.75 B +$217 M $31.81 229
2016 Q2 110 M $3.59 B +$35.4 M $32.46 223
2016 Q1 110 M $3.06 B +$338 M $27.96 210
2015 Q4 97.3 M $3.47 B -$45.9 M $35.65 206
2015 Q3 98.5 M $3.26 B +$12.9 M $33.07 184
2015 Q2 97.4 M $4.08 B +$68 M $41.88 188
2015 Q1 97.3 M $3.17 B +$38.3 M $32.59 193
2014 Q4 96.2 M $3.06 B +$57.9 M $31.75 180
2014 Q3 94.2 M $2.33 B -$12.9 M $24.76 161
2014 Q2 95 M $2.15 B +$93.9 M $22.59 158
2014 Q1 90.8 M $2.21 B +$190 M $24.33 162